Immatics Biotechnologies
Immatics Biotechnologies is a biopharmaceutical company focused on the discovery and development of immunotherapy of cancer.
Key facts
| Also Known As | Immatics |
|---|---|
| AngelList URL | https://angel.co/immatics-biotechnologies |
| Business Model | Commerce |
| Legal Name | Immatics N.V. |
| Company Operating Status | Active |
| Crunchbase URL | https://www.crunchbase.com/organization/immatics-biotechnologies |
| Full Address | 2201 W. Holcombe Blvd., Suite 205, Houston, Texas 77030 |
| LinkedIn URL | https://de.linkedin.com/company/immatics-biotechnologies |
| Pitchbook URL | https://pitchbook.com/profiles/company/11025-46 |
| Ticker Symbol | IMTX |
| Twitter URL | https://twitter.com/immatics |
| Official Website | http://immatics.net |
| Wellfound ID | immatics-biotechnologies |
| Wikidata ID | Q30256960 |
Contact details
Email and phone for Immatics Biotechnologies are available to signed-in members of PharmaLyt.
Sign in to view